Magnetotherapy device

 

(57) Abstract:

The invention relates to medical equipment, namely, magnetic therapy, and can be used in the treatment of many diseases, including cirrhosis of the liver complicated forms in the course of regeneration of dysfunctional organs, the treatment of BPH, provides painless crushing and output concretions of various organs, treats mastitis and fibroadenoma of the mammary glands and uterine fibroids, atherosclerosis of vessels of lower extremities and many others without surgery and without the use of medication. The device contains a bed to accommodate the patient and means generating a magnetic field, mounted for movement along the bed, one under the bed, the other above it, means for generating magnetic fields installed with the possibility of moving along above the bed rigidly mounted on the base, is arranged to move up and down, and includes placed on the supporting disk installed with the possibility of angular displacement of the output element of the actuator, permanent magnets, one of which is placed in the center, and the other provided with a magnetic circuit, the shape and size of kotoraja. The reference disk is placed in a protective casing of magnetocapacitive material on the end of which there is a safety net of magnetocapacitive material, closed plexiglass, while the bed is equipped with a headrest, made with the possibility of movement, and additional means for generating magnetic fields. For the implementation of impact on the feet, additional means of generating a magnetic field placed at the end of the bed, firmly established on a different basis and includes placed on the supporting disk installed with the possibility of angular displacement of the output element of the actuator, permanent magnets, equipped with a similar shape and dimensions of the magnetic circuit. Magnets with the magnetic circuit is installed on the drive angle 120oat equal distance from the center, and the reference disk is placed in a protective casing of magnetocapacitive material with a hole in the form of permanent magnets, but with the broadening on the edge of the protective casing, and closed the plexiglass. An additional device for generating a magnetic field includes also an additional source of magnetic field in the form of a permanent magnet with a magnetic circuit made according to the shape and dimensions of the permanent magnet, CA the holes in the protective cover. Means for generating magnetic fields installed with the possibility of angular displacement along under the bed, includes cart, mounted in the bed can move under it and is made of two four-sided pyramids, set one within the other upside down on the walls of which are placed rows of permanent magnets mounted to the outside poles N, while the walls of pyramids made of magnetoresitive material. The technical result is to increase functionality and efficiency impacts. 1 C.p. f-crystals, 11 ill.

The invention relates to medical equipment, namely, magnetic therapy, and can be used in the treatment of many diseases, including cirrhosis of the liver complicated forms, the implementation of the regeneration of dysfunctional organs, BPH, painless crushing and output concretions of various organs, mastitis and fibroadenoma of the mammary glands and uterine fibroids, atherosclerosis of vessels of lower extremities and many others without surgery and without the use of medication.

A device for generating magnetic fields of the class a 61 N 2/12 under the patent of the Russian Federation 2080891 the three groups of permanent magnets, two in each, and the groups placed on the supporting disk angle 120oand at an equal distance from the center of the supporting disc, a hole is made in the form of permanent magnets and located at the same distance from the center of the support disc, and on the basis of an additional source of magnetic field of permanent magnets mounted on an axis located at an angle =90oto the axis of the actuator in one plane with this axis and the hole axis of the screen.

This invention makes a significant penetration depth magnetoionic lines in the human body through the use of the impact of the interacting magnetic field angle =90o. Using this exposure gave a new impetus to the development of domestic magnetobiology. Since such an effect on a biological object is such a modulation of the direction vectors of the magnetic fluxes, which when exposed to opposite poles at an angle =90ocreates sustained waves linear forms with high energy, when exposed to the same pole angle =90o- sustained waves spiral forms with hidden energy, while simultaneously impacts on linear and spiral forms - the effect of the cross. Such sustained waves affect the movement of the seven spectra of light in the human body, so a complete cure provides length information in the human body. The role of the magnetic field when the effect is to provide characteristics in the form of autowaves, which affect the movement of the spectra of light, and excites these spectra light.

That is why this device was to cure cirrhosis of the liver through the implementation of the regeneration of the damaged cells in the liver. During treatment, the liver becomes normal size and normal fine-grained structure (with cirrhosis and coarse - grained structure). The liver is almost reborn. Also other diseases gallstone, kidney stones, BPH, cystic lesion of various organs and many others.

Known similar device under the patent of Ukraine 15368 A, class a 61 N 2/12, at the request 95114829 from 09.11.95, which authors are centuries of Malashenok, Y., Putilov and O. F. Petrenko. Applicant - Dneprovsky iron & steel works named after Dzerzhinsky.

Also known device for generating magnetic fields and the effects of magnetic field on the patent is. This device is intended for fast and painless crushing concrements from the gall bladder and ducts, kidneys and urinary tract and prostate gland, as well as the disappearance of cysts, nodes, cure BPH and changing the grain size of the liver.

Existing in the world magnetotherapy devices when the generation of magnetic fields on biological object is such a modulation of the direction vectors of the magnetic fluxes, which when exposed to the human body creates sustained waves of nonlinear (hyperbolic) form. Such sustained waves affect the bioelectrical information in the human body.

However, the main disadvantage of the above device for generating a magnetic field angle =90ois the inability of a wide range of magnetotherapy effects on various diseases, as when interacting angle =90othe beam has a finite width effects. In addition, the location of the individual structural elements of the device does not allow a sufficient degree of convenience to conduct the treatment of several diseases, such as, for example, paraprosthetic, or diseases of a bladder - cisewski the device according to the Korea patent N WO 95/04572 A1 from 16.02.1995,, class a 61 N 2/12.

This invention uses the bed to accommodate the patient and means generating magnetic fields: one is under the bed, the other above it.

The basis of the present invention the task is improving the magnetotherapy device that by design changes to the device for generating magnetic fields and the introduction of the beds with built in trolley, made of two four-sided pyramids, installed one in one upside down on the walls of which are placed rows of permanent magnets mounted to the outside poles N, while the walls of pyramids made of magnetoresitive material with the ability to move and to interact with the main unit at an angle 2=180owith the purpose of through penetration of the biological object magnetovolume lines, in addition, introduces an additional means of generating magnetic fields, which is installed on the end of the bed and the headrest can be moved, as well as the introduction of additional rows of permanent magnets with magnetic circuits of magnetoresitive material made according to the shape and size of the permanent magnets on the supporting disk with simultaneous effects on various diseases with the use of through-penetration magnetovolume lines of the human body at an angle 2=180owith the simultaneous use of autowaves linear forms with high energy, autowaves spiral forms with hidden energy and effect of the cross, reducing the time of treatment, therefore, increases the throughput of the apparatus for the treatment of patients from severe diseases and increases ease of use.

The problem is solved in that the device for generating magnetic fields, containing the bed to accommodate the patient and means for generating magnetic fields installed with the possibility of moving along the bed, one under the bed, the other over it, and according to the invention that the means for generating magnetic fields installed with the possibility of moving along above the bed rigidly mounted on the base, is arranged to move up and down, and includes placed on the supporting disk installed with the possibility of angular displacement of the output element of the actuator, permanent magnets, one of which is placed at the center, and the other is provided with a magnetic circuit, the shape and size similar to the size and shape of the permanent magnets, and is installed on drive series angle 120othree in each.

The reference disk is gnanaprakasam material, closed plexiglass, while the bed is equipped with a headrest, made with the possibility of movement, and additional means for generating magnetic fields to influence the feet additional means for generating a magnetic field placed at the end of the bed, firmly established on a different basis and includes placed on the supporting disk installed with the possibility of angular displacement of the output element of the actuator, permanent magnets, equipped with a similar shape and dimensions of the magnetic circuit. Magnets with the magnetic circuit is installed on the drive angle 120oat equal distance from the center, and the reference disk is placed in a protective casing of magnetocapacitive material with a hole in the form of permanent magnets, but with the broadening on the edge of the protective casing, and closed the plexiglass.

Additional means of generating a magnetic field includes also an additional source of magnetic field in the form of a permanent magnet with a magnetic circuit made according to the shape and dimensions of the permanent magnet and mounted on the rod located at an angle of 90oto the axis of the actuator in one plane with this axis and the axis of the hole in the protective cover. Credit cart, mounted in the bed can move under it and is made of two four-sided pyramids, set one within the other upside down on the walls of which are placed rows of permanent magnets mounted to the outside poles N, while the walls of pyramids made of magnetoresitive material.

In the proposed magnetotherapy device using permanent magnets with magnetic induction of 0.3-1.3 T.

The invention is illustrated by drawings, where:

in Fig.1 shows a General view of magnetotherapy device;

in Fig.2 - platter, side view;

in Fig. 3 - platter with three rows, with three groups in each of the permanent magnets and the center of the disc permanent magnet;

in Fig.4 - means for generating magnetic fields with the lifting mechanism;

in Fig. 5 - wooden bed with headrest, with the ability to move;

in Fig.6 bed with trolley, made of two four-sided pyramids, installed one in another, tops down;

in Fig.7 is a view of the trolley, made of two four-sided pyramids;

in Fig.8-11 is an additional means of generating magnetic fields.

Magnetotherapy device which is a plate of magnetocapacitive material, which is attached inside the box 11, the source of the magnetic field 3, is placed on the supporting disk 4, is made of thick PCB in the center of 40 mm, on the edge of a disk 20 mm in diameter, 600 mm, with cells under permanent magnets with a diameter of 66 mm and a depth of 15 mm with the possibility of angular displacement of the output element of the actuator 1 with promblem 5.

The source of the magnetic field 3 consists of three rows of permanent magnets on three groups in each row in each group by a single magnet and a single magnetic core made according to the shape and size of the permanent magnets, in the form of rings with an outer diameter of 65 mm, an inner - 10 mm and thickness of 10 mm, which are mounted in the cells of the supporting disc 4 so that the disk surface 4 of their serving portion was equal to 5 mm, and placed at an angle of 120oand each row separately at equal distance from the center of the support disk 4, which is closed by the protective cover 8 of magnetocapacitive material at the end of which the protective grid 9 of magnetocapacitive material is covered by a plexiglass 10, and the casing 8 is attached to the bottom of the drawer 11, the cover of which is rigidly attached to the vertical rod 12 with the tape threaded, and the vertical rod 12 with a large nut 13 that is required when lifting, euskadiko 17 to the bars 15, connecting the rack 16, which are also connected by rungs. For communication the primary means of generating a magnetic field at an angle 2=180oadditionally, we introduce wooden bed 17 with headrest 18 with the ability to move, the bed 17 has the following dimensions: length - 2000 mm; width - 900 mm, height - 550 mm

Inside the bed 17 has a large cart with bearings 19 on the axis 20, by means of which the carriage 19 is moved to the bars 23 by means of handles 22.

Big truck 19 is made of two terrenganu pyramids installed one in another, tops down, having dimensions 600600400 mm, the dimensions of each face are 600583 mm, the dimensions of each face the other pyramids are h mm installed on the inner walls and outer walls of the other pyramid flat permanent magnets 21, and is installed between unlike poles, and set out poles N on all the walls of the pyramid. Thus groups of magnets installed between a prescribed interval for the interaction between groups of magnets. Both pyramids are made of magnetoresitive material CT-3, so the walls of the pyramids perform the role of magnetic circuits. Ispolzueschemu 24 wood, and on top of plastic material 25, on which is placed a light blanket on top of the bedclothes.

The box 11 has dimensions: length - 500 mm; width - 250 mm; height - 300 mm

On the side of the box 11 is fixed handle 29, is necessary for adherence to the main unit during the rotation of the large nut 13, the diameter of which is 100 mm, with dimensions 32032050 mm, there is a sleeve 32, which passes the rod 12, equipped with a screw thread, and the side of the truck 14 to secure the lever with the sleeve 30, is necessary for the guide 31, which is attached to the top cover of the drawer 11 and necessary that the drawer 11 is not rotated on a vertical rod 12. In addition, the side on a small cart 14 includes a brake 26 in the form of a bracket with a bolt, which is pressed to the bars 15, which moves a small trolley 14. At the end of the bed 17 is provided additional means for generating a magnetic field 27 with stand 28 provided for the foot of the patient.

Additional means for generating a magnetic field includes: actuator 1A, rigidly attached to the base 2A, the source of the magnetic field 3A placed in the cells of the supporting disc 4A made of textolite thickness of 20 mm, a diameter of 220 mm with the possibility of angular displacement is gnome magnet and a magnetic circuit, made on the shape and size of the permanent magnets of magnetoresitive material, in each group, and groups are angled 120oand at an equal distance from the center of the supporting disc 4A and installed so that the surface of the disk, the protruding portion was equal to 5 mm, and are anchored in the cell by means of bolts and nuts with washers from magnetocapacitive material, and the torque reference disk 4A one protective casing of magnetocapacitive material with a hole made in the form of permanent magnets, but with the broadening on the edge of the disk 4A to ensure the smooth passage of the beam, and a fixed plexiglass and at the same distance from the center of the supporting disc 4A with permanent magnets, and an additional source of magnetic field 6A, made of a permanent magnet and a magnetic circuit from magnetoresitive material made according to the shape and dimensions of the permanent magnet 6A, which is fastened to the rod 5A and the rod 5A is attached to the protective casing and is under =90oto the axis of the actuator in one plane with this axis and the axis of the hole in the protective casing, the rod 5A is attached to the protective casing, and the device is attached to the end of the bed 17.

When using veritable in the form of magnets, used section 4-5 mm. rotation of the supporting disks in primary and secondary means for generating is performed counterclockwise with the intention that when exposed to the human body generating magnetic fields was carried out clockwise.

Magnetotherapy device operates as follows.

The patient lies on a bed 17, the pre-personal bed sheets on his stomach or on his back, with the help of handles 22, fixed to the large truck 19, move it along the bed 17 in the desired area of treatment of the patient, then moved a small cart 14 to the bars 15 above the bed 17 to communicate with the truck 19. Using a large nut 13 by the rotation drop over the body of the patient is the primary tool for generating magnetic fields, and then turn on the actuator 1, and is magnet therapy session with a duration of 5-10 minutes, and more if necessary. If the patient is in the process of session yawn is evidence of a decline in blood pressure, then you have a foot left foot to cradle 28 heel before additional means 27 for generating magnetic fields, including it. The duration of the session in the foot of the left leg up to 5 min and b is disappears and the patient feels vigor, ease away pain syndromes (if they occurred). Similarly treated atherosclerosis of vessels of lower extremities, brain, pituitary adenoma and cardiovascular disease, in which there is no need of a replacement heart valve surgery.

For the treatment of gastrointestinal, urological and other diseases are flat permanent magnets 21 with the magnetic circuit, which is installed on the inner walls of the truck 19, made of two four-sided pyramids outside poles n And on the supporting disk 4 main unit permanent magnets 3 with the magnetic circuits are installed in cells outside the poles of the S, but each row has one cell from the edge of the support disk 4 to the center of the permanent magnets 3 are installed to the outside poles N, and in the center of the disc 4, the permanent magnet to the outside pole S. additional means of generating magnetic fields of permanent magnets set out in the cells of the supporting disc 4A poles N and on the rod 5A installed an additional source of magnetic field 6A output pole S to interact angle =90o.

Example 1. The patient Including, 12.09.71 born, resident, Dneprodzerzhinsk, was, Moskvich turned 03.02.99, in the Central city hospital, Queens, Tsiolkovsky street, 24. After the examination and treatment of the mother of the patient is recommended to immediately take home, in Ukraine, as in the near future expected to be lethal, the patient is not the tenant! (from the words of the patient). The presence of bilirubin in the blood was 286 at the rate of 20 free fluid in the abdominal cavity (ascites), cirrhosis of the liver, the spleen is enlarged two times more than normal.

Ultrasound of 24.02., made in sanatorium-preventorium DPO "Azot", Dneprodzerzhinsk, confirmed the presence of cirrhosis with ascites.

At the first session of magnetotherapy patient almost brought on his hands.

After the first treatment, blood tests showed the presence of bilirubin in the blood 28 at the rate of 20 (and was 286). Ultrasound from 30.04.99, showed that there is no fluid in the abdominal cavity, the liver was significantly reduced in size. Of coarse patterns were transformed into fine-grained to medium-grained areas - hepatitis.

After additional treatment ultrasound from 24.05.99, showed that the liver has fully acquired the fine-grained structure was drastically reduced to normal spleen (see photocopies ultrasound). The most important thing is the patient physically stronger and returned prostatic hypertrophy.

Ultrasound dated 01.03.99, showed that the prostate gland is about the size 5,35,64,0 cm at a maximum rate 4,04,23,3 see also visible on the prostate gland compacted node rounded shape, size 1,91,8 see

After one course of therapy (20 sessions with a duration of 10 minutes) ultrasound of 14.05.99, showed that the prostate gland has become normal dimensions, namely: 3,84,03,3 see Condensed node is also decreased to 1,31,1 see

The patient was asked to undergo another course of treatment to completely get rid of the seals on the prostate gland, but the patient felt the man's strength, joy, decided to wait a little.

The effectiveness of the proposed magnetotherapy device depends on latitude magnetotherapy effects on various diseases with through penetration of the human body magnetovolume lines, the duration of the session (more time is better) with the simultaneous use of when generating magnetic fields of autowaves linear forms with high energy, autowaves spiral forms with hidden energy, and simultaneous exposure to these autowaves effect of the cross.

That is Bo 2=180oat the moment of generation of magnetic fields and affect the movement of the seven spectra of light in the human body, therefore, a complete cure carries a light, the information included in the body according to the formula, the dependence of which can be represented as the following equation:

< / BR>
where the luminous intensity depends on the amount of induced spectra of light in the presence of radiation (small values of the investigated activities for all life on Earth).

And existing in the world magnetotherapy devices that generate magnetic fields are formed sustained waves of nonlinear (hyperbolic) form, which affect the bioelectrical information in the human body, therefore, the treatment provides bioelectrical information, which is one of the main differences in the method of treatment laid down in the proposed magnetotherapy device, and when it is full cure many severe diseases and increases ease of use.

Magnetotherapy device can be used in clinics, hospitals, sanatoria-dispensaries and other medical of facilities and means of generating magnetic fields, mounted for movement along the bed, one under the bed, the other above it, wherein the means for generating magnetic fields installed with the possibility of moving along above the bed rigidly mounted on the base, is arranged to move up and down, and includes placed on the supporting disk installed with the possibility of angular displacement of the output element of the actuator, permanent magnets, one of which is placed in the center, and the other provided with a magnetic circuit, the shape and size similar to the size and shape of the permanent magnets, and is installed on drive series angle 120othree in each, the reference disk is placed in a protective casing of magnetocapacitive material on the end of which there is a safety net of magnetocapacitive material, closed plexiglass, while the bed is equipped with a headrest, made with the possibility of movement, and additional means for generating magnetic fields to influence the feet additional means of generating a magnetic field placed at the end of the bed, firmly established on a different basis and includes placed on the supporting disk installed with vozmojnostyam the magnetic circuit, magnets with the magnetic circuit is installed on the drive angle 120oat equal distance from the center, and the reference disk is placed in a protective casing of magnetocapacitive material with a hole in the form of permanent magnets, but with the broadening on the edge of the protective casing, and closed the plexiglass, additional means for generating a magnetic field includes also an additional source of magnetic field in the form of a permanent magnet with a magnetic circuit made according to the shape and dimensions of the permanent magnet mounted on the rod at an angle 90oto the axis of the actuator in one plane with this axis and the axis of the hole in the protective casing, means for generating magnetic fields installed with the possibility of angular displacement along under the bed, includes cart, mounted in the bed can move under it and is made of two four-sided pyramids, installed one in one upside down on the walls of which are placed rows of permanent magnets mounted to the outside poles N, while the walls of pyramids made of magnetoresitive material.

2. The device under item 1, characterized in that use permanent magnets with magnetic induction of 0.3-1

 

Same patents:

The invention relates to medical equipment and can be used for magnetic therapy, and to examine the effect of variable low frequency of vortex magnetic fields on biological objects

The invention relates to medicine and intended for the introduction of ions of metallic silver

The invention relates to medical equipment, namely, magnetic therapy, and can be used in the treatment of liver cirrhosis, hepatitis, pancreatitis, peptic ulcer disease of stomach and duodenal ulcer twelve, for painless crushing and output concretions from the liver, gallbladder, kidneys, pancreas and bladder, prostatic hypertrophy, in the treatment of mastitis and fibroadenoma of the mammary glands, atherosclerosis of vessels of lower extremities, radiculitis, osteochondrosis
The invention relates to medicine, in particular to urology
The invention relates to methods of magnetic therapy

The invention relates to medicine, namely to transplantation, and is intended for the treatment of burn wounds

The invention relates to medicine, cardiology
The invention relates to medicine, namely physiotherapy, and can be used for healing the body when deviations from normal physiological parameters, as well as for prevention and treatment of diseases associated with neuro-functional disorders
The invention relates to medicine, cosmetology

FIELD: medicine.

SUBSTANCE: method involves making incision in conjunctiva and Tenon's capsule of 3-4 mm in size in choroid hemangioma projection to sclera 3-4 mm far from limb. Tunnel is built between sclera and Tenon's capsule to extrasclerally introduce flexible polymer magnetolaser implant through the tunnel to the place, the choroid hemangioma is localized, after performing transscleral diaphanoscopic adjustment of choroid hemangioma localization and size, under visual control using guidance beam. The implant has permanent ring-shaped magnet in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 2-3 mTesla units intensity. It is arranged with its north pole turned towards the choroid hemangioma so that extrascleral implant laser radiator disposition. The other end of the implant is sutured to sclera 5-6 mm far from the limb with two interrupted sutures through prefabricated openings. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. 0.1-1% khlorin solution is injected in intravenous bolus dose of 0.8-1.1 mg/kg as photosensitizer and visual control of choroid hemangioma cells fluorescence and fluorescent diagnosis methods are applied. After saturating choroid hemangioma with the photosensitizer to maximum level, transscleral choroid hemangioma laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm with total radiation dose being equal to 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the intraocular neoplasm, repeated laser irradiation of the choroid hemangioma is carried out with radiation dose of 30-60 J/cm2.

EFFECT: enhanced effectiveness of treatment.

4 cl

FIELD: medicine.

SUBSTANCE: method involves creating tunnel between sclera and Tenon's capsule in intraocular neoplasm projection. Intraocular neoplasm localization and size is adjusted by applying transscleral diaphanoscopic examination method. 0.1-0.3 ml of photosensitizing gel based on viscoelastic of hyaluronic acid, selected from group containing chealon, viscoate or hyatulon, is transsclerally introduced into intraocular neoplasm structure using special purpose needle in dosed manner. The photosensitizing gel contains khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-1% by mass. Flexible polymer magnetolaser implant is extrasclerally introduced into the built tunnel in intraocular neoplasm projection zone under visual control using guidance beam. The implant has permanent ring-shaped magnet axially magnetized and producing permanent magnetic field of 3-4 mTesla units intensity, in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The implant is arranged with its north pole turned towards the intraocular neoplasm so that implant laser radiator lens is extrasclerally arranged in intraocular neoplasm projection zone. The implant light guide is sutured to sclera 5-6 mm far from the limb with single interrupted suture. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transscleral intraocular neoplasm laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm. The treatment course being over, the flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, neodymium-iron-boron or samarium-iron-nitrogen. 0.1-1% khlorin solution as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is additionally intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg and repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm2 15-20 min later during 30-90 s.

EFFECT: complete destruction of neoplasm; excluded its further growth.

4 cl

FIELD: medicine.

SUBSTANCE: method involves building tunnel to posterior eyeball pole in inferoexterior and superexterior quadrants. The tunnel is used for implanting flexible polymer magnetolaser implant to the place, the subretinal neovascular membrane is localized. The implant has a permanent magnet shaped as a cut ring and is provided with drug delivery system and a short focus scattering lens of laser radiator connected to light guide. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 5-7 mTesla units intensity. It is arranged with its north pole turned towards sclera at the place of the subretinal neovascular membrane projection with extrascleral arrangement of laser radiator lens membrane being provided in the subretinal neovascular membrane projection area. The other implant end is sutured to sclera 5-6 mm far from the limb via holes made in advance. The implant is covered with conjunctiva and retention sutures are placed thereon. Light guide and drug supply system lead is attached to temple with any known method applied. Drugs are supplied via the implant drug supply system in retrobulbary way in any order. Triombrast is given in the amount of 0,4-0,6 ml and dexamethasone or dexone in the amount of 0,4-0,6 ml during 3-4 days every 12 h. 0.1-1% aqueous solution of khlorin is intravenously introduced at the third-fourth day after setting the implant as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, at a bolus dose of 0.8-1.1 mg/kg. Visual control of subretinal neovascular membrane cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the subretinal neovascular membrane with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at general dose of 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the subretinal neovascular membrane via laser light guide and implant lens, repeated laser irradiation of the subretinal neovascular membrane is carried out with radiation dose of 30-60 J/cm2.

EFFECT: accelerated subretinal edema and hemorrhages resorption; regression and obliteration of the subretinal neovascular membrane; prolonged vision function stabilization.

6 cl

FIELD: medicine.

SUBSTANCE: method involves carrying out transpupillary laser avascular zones coagulation. Taurin is dropped into conjunctival cavity at a dose of 1-2 drops into the eye under treatment 5-6 times a day during 7-10 days. 0.02% Histochrome solution is dropped into conjunctival cavity at a dose of 2 drops into the eye under treatment 5-6 times a day during 7-10 days. 0.02% Histochrome solution or 0.02% Emoxipin solution or 1% Retinalamine solution in the amount of 0.4-0.6 ml once a day is parabulbary introduced as antioxidant during 7-10 days. Magnetic stimulation course is applied on the background of conservative therapy to orbital or temporal head region of prematurely born child in any succession using external rotating permanent magnetic field of 0.15-0.40 mTesla units intensity. Periodicity of external magnetic field action is selected to be 1-2 times per day with external action duration being equal to 3-5 min per 1 session during 10 days with magnetic field being 15-30 cm far from orbital or temporal head region of prematurely born child. External permanent magnetic field rotating at constant or variable speed is applied for carrying out magnetic stimulation treatment. Repeated conservative therapy and magnetic stimulation treatment with external rotating permanent magnetic field is additionally applied in 1-3 months. The number of repeated courses is equal to 1-3.

EFFECT: enhanced effectiveness of prophylactic treatment; prevented severe disease forms progress; released retina edema; improved blood circulation in avascular zones.

3 cl

FIELD: medicine.

SUBSTANCE: method involves carrying out transpupillary laser coagulation of central avascular zones and transscleral cryocoagulation of peripheral avascular retina zones. 3-4 mm long incisions in conjunctiva and Tenon's capsule are done between sclera and Tenon's capsule in perpendicular to limbus 3-4 mm far from it. Tunnel is built in projection zone of an avascular retina zone between sclera and Tenon's capsule in parallel to the limbus on both sides of the incision. Flexible polymer magnetic implant is extrasclerally introduced into the tunnel in projection zone of an avascular retina zone. The implant has its own permanent magnetic field with magnetic poles alternating on each of sides and permanent magnetic field intensity of 0.5-1.0 mTesla units. The implant is sutured with one of its ends to sclera, and suture is placed on conjunctiva, and anti-oxidant therapy is applied. Magnetic stimulation therapy course is applied 3-4 weeks later. The course combines actions of permanent magnetic field produced by extrasclerally arranged magnetic implant and external rotating permanent magnetic field of 0.30-0.40 mTesla units intensity. Periodicity of external magnetic field action is selected to be 1-2 times per day with external action duration being equal to 3-5 min per 1 session during 10 days. The extrasclerally arranged flexible polymer magnetic implant is removed when treatment course is over. The flexible polymer magnetic implant is manufactured from biologically stable polymer material like one on polypropylene, polyester or polyethylene basis having permanent magnet material powder particles uniformly distributed therein. Magnetic material particles are of samarium-cobalt, neodymium-iron-boron or samarium-iron-nitrogen base.

EFFECT: enhanced effectiveness of prophylactic treatment; prevented severe disease forms progress; released retina edema.

6 cl

FIELD: medicine.

SUBSTANCE: method involves carrying out vitrectomy with posterior hyaline membrane being removed. Retinotomy is carried out with subretinal neovascular complex being removed. Autogenous pigment retinal epithelium is subretinally introduced through retinotomy area as stratum or suspension. The intravitreous tamponade is carried out with perfluororganic compound substituted with air next to it. Flexible polymer magnetolaser implant having ring-shaped magnet with axial permanent magnetic field magnetization of 3-7 mTesla units is extrasclerally mounted into tunnel built between sclera and Tenon's capsule in macular area projection zone. The implant is turned with S pole towards transplanted cells so that laser radiation-emitting lens is arranged in their projection zone. Implant light guide is sutured to sclera 5-6 mm far from limb. The implant is covered with conjunctiva. Light guide outlet is attached to temple. The introduced cells are treated via laser light guide and implant lens with divergent continuous laser radiation. The magnetic implant is removed after having finished the treatment course and sutures are placed on conjunctiva.

EFFECT: enhanced effectiveness of treatment.

FIELD: medical engineering.

SUBSTANCE: method involves acting in turn with ultrasonic and magnetic field with switch frequency of 10 to 160 Hz. Ultrasonic field intensity is set below cavitation threshold and ultrasonic oscillation frequency being equal to liquid acoustic relaxation frequency. Magnetic field induction being selected within the limits of 30-50 mTesla units.

EFFECT: enhanced effectiveness of liquid activation; reduced power consumption.

1 dwg

FIELD: medicine, surgery.

SUBSTANCE: the present innovation deals with operative interference followed by the impact with magnetolaser infrared radiation of 80 Hz frequency per 30 sec or 2-4 fields and with direct magnetic field at the value of magnetic induction being 25-50 mTl for 10-20 min successively. At first, one should affect postoperational area, the - reflexogenic area at one's foot, daily for 8-12 d. Since the 9th - 13th d one should affect with single direct magnetic field with the value of magnetic induction being 25-50 mTl for 10-20 min successively. At first, one should affect postoperational area, then - reflexogenic area at one's foot for 10 -12 d. The innovation decreases the frequency of postoperational complications.

EFFECT: shortened terms of therapy.

2 ex

Medical applicator // 2269368

FIELD: medical engineering.

SUBSTANCE: device has metal casing having permanent magnet inside. Electrode is outside of the casing and connected to electric current source. The second electrode, manufactured from non-magnetic material having cavity, is inside of the casing. Permanent magnetic is mounted in the cavity. Substance like mineral solution or plant oil is placed between the electrodes. Dielectric bushing is mounted in the casing for insulating electrodes and substance from the casing. Electric current supply source is mounted with one of its contacts on the first electrode and with its second electrode having ironwork fault. One of applicator embodiments has spring placed between electric current supply source and casing. Another version has electrode mounted outside of the casing. It is manufactured from nonferrous metal having silver coating.

EFFECT: wide range of functional applications.

3 cl, 1 dwg

FIELD: medicine.

SUBSTANCE: method involves rectally exposing prostate projection zone to red, infrared radiation, magnetic field and magnetic therapy is applied to sacral region, pubis and perineum. Magnetized sapropelic tampon is introduced into the rectum after applying combined rectal treatment. Tampon volume is equal to 140-160 ml and hold for 30-40 min under temperature of 37-38°C and magnetic therapy is applied to sacral region, pubis and perineum region.

EFFECT: wide range of therapeutic applications.

Up!